Stocks and Investing Stocks and Investing
Fri, February 17, 2023
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Hammond Maintained (WSO) at Buy with Increased Target to $365 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Manthey Maintained (WSO) at Buy with Increased Target to $350 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Mike Matson Maintained (AORT) at Strong Buy and Held Target at $23 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Mark Marcon Maintained (AMN) at Hold with Decreased Target to $111 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jonathan Yong Reiterated (AMN) at Buy and Held Target at $147 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Tyler Radke Maintained (AMPL) at Hold with Increased Target to $16 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Devin Dodge Maintained (WCN) at Buy with Decreased Target to $153 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Toni Kaplan Maintained (WCN) at Buy with Increased Target to $164 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Steve Barger Maintained (WAB) at Buy with Increased Target to $112 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Ali Faghri Downgraded (VC) to Hold on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Luke Junk Maintained (VC) at Buy with Increased Target to $170 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Mark Delaney Maintained (VC) at Strong Buy with Increased Target to $180 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Colin Langan Maintained (VC) at Sell with Increased Target to $125 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Edward White Reiterated (VALN) at Strong Buy and Held Target at $25 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Lauren Silberman Maintained (USFD) at Buy with Increased Target to $47 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
John Glass Maintained (USFD) at Hold with Increased Target to $46 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Shelby Tucker Maintained (UTL) at Hold with Increased Target to $56 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Gesuale Downgraded (AXON) to Buy and Held Target at $223 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Arun Viswanathan Upgraded (AXTA) to Buy and Increased Target to $36 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Charles Shi Maintained (AXTI) at Strong Buy with Increased Target to $8 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Richard Shannon Downgraded (AXTI) to Hold on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Kang Maintained (AXTI) at Hold with Decreased Target to $5 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Tito Labarta Maintained (BBD) at Hold with Decreased Target to $2.7 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Tito Labarta Maintained (BBDO) at Hold with Decreased Target to $2.7 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Meuler Maintained (BFAM) at Hold with Increased Target to $76 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
George Tong Maintained (BFAM) at Strong Buy with Decreased Target to $82 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Dana Telsey Reiterated (BBWI) at Buy and Held Target at $52 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Ami Fadia Maintained (BPMC) at Strong Buy with Decreased Target to $57 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Andrew Fein Reiterated (BPMC) at Strong Buy and Held Target at $70 on, Feb 17th, 2023
[ 12:00 AM ] - United States, WOPRAI
Dane Leone Maintained (BPMC) at Strong Buy with Decreased Target to $85 on, Feb 17th, 2023

Dane Leone Maintained (BPMC) at Strong Buy with Decreased Target to $85 on, Feb 17th, 2023


Published on 2024-10-28 01:43:48 - WOPRAI, Dane Leone
  Print publication without navigation


Dane Leone of Raymond James, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Decreased Target from $115 to $85 on, Feb 17th, 2023.

Dane has made no other calls on BPMC in the last 4 months.



There are 9 other peers that have a rating on BPMC. Out of the 9 peers that are also analyzing BPMC, 5 agree with Dane's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $50 on, Friday, January 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Hold with Decreased Target to $44 on, Monday, January 23rd, 2023
  • Derek Archila of "Wells Fargo" Upgraded from Sell to Hold and Held Target at $41 on, Tuesday, January 3rd, 2023
  • Matthew Biegler of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, November 2nd, 2022
  • Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $52 on, Wednesday, November 2nd, 2022


These are the ratings of the 4 analyists that currently disagree with Dane

  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $114 on, Monday, February 6th, 2023
  • Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $108 on, Thursday, November 3rd, 2022
  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $106 on, Wednesday, November 2nd, 2022
  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Decreased Target to $85 on, Wednesday, November 2nd, 2022

Contributing Sources